Welcome! Accelerate Your Discovery

Be a part of a committed society that is shaping the future of knowledge Search

Efruxifermin in Compensated Liver Cirrhosis Caused...
Mazen Noureddin, Mar...
Efruxifermin, MASH (metabolic dysfunction-associated steatohepatitis), liver cirrhosis, FGF21 analogue, fibrosis reduction, compensated cirrhosis, clinical trial, metabolic liver disease

This phase 2b randomized, double blind, placebo controlled trial evaluated the efficacy and safety o... 6 months ago